Hypereosinophilia

Current Opinion in Hematology

Volumn 7, Issue 1, 2000, Pages 21-25

  Bain, Barbara J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

BONE MARROW TRANSPLANTATION; EOSINOPHILIC LEUKEMIA; HUMAN; HYPEREOSINOPHILIA; IDIOPATHIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYNDROME; T LYMPHOCYTE ACTIVATION;

CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPEREOSINOPHILIC SYNDROME; T-LYMPHOCYTES;

EID: 0033989934     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200001000-00005     Document Type: Review

References (38)

1. 1 Bain BJ: Eosinophilic leukemia and the idiopathic hypereosinophilic syndrome. Br J Haematol 1996, 95:2-9.
2. 2 Yamada T, Shinohara K, Katsuki K: A case of idiopathic hypereosinophilic syndrome complicated with disseminated intravascular coagulation. Am J Hematol 1998, 58:100-101.
3. 3 Luppi M, Marasca R, Morselli M, Barozzi P, Torelli G: Clonal nature of the hypereosinophilic syndrome. Blood 1994, 84:349-350.
4. 4 Chang H-W, Leong K-H, Koh D-R, Lee S-H: Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood 1999, 93:1651-1657. This study demonstrates that investigations of X-linked polymorphisms of the Humara gene can provide evidence of a clonal population of eosinophils in the otherwise unexplained hypereosinophilic syndrome.
5. 5 Raghavacher A, Fleischer S, Frickhofen N, Heimpel H, Fleischner S: T lymphocyte control of human eosinophilic granulopoiesis: clonal analysis of an idiopathic hypereosinophilic syndrome. J Immunol 1990, 139:3753-3758.
6. 6 Cogan E, Schandené L, Cogan E, Crusiaux A, Cochaux P, Velu T, Goldman M: Clonal proliferation of type 2 helper T cells in a man with hypereosinophilic syndrome. New Engl J Med 1994, 330:535-538.
7. + T-cells with chromosome 16 abnormalities. Br J Haematol 1996, 92:315-317.
8. 8 Bank I, Reshef A, Beniaminov M, Rosenthal, E, Rechavi G, Monselise Y: Role of gamma/delta T cells in a patient with CD4+CD3-lymphocytosis, hypereosinophilia, and high levels of IgE. J Allergy Clin Immunol 1998, 102:621-630.
9. 9 Roufosse F, Schandene L, Sibille C, Kennes B, Efira A, Cogan E, Goldman M: T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood 1999, 94:994-1002. This investigation established that in some cases neoplastic T cell clones synthesizing IL-5 and giving rise to hypereosinophilia are not autonomous but require signaling through accessory cells.
10. 10 Bain BJ: Interactive Haematology Imagebank (CD-ROM). Blackwell Science, Oxford; 1999.
11. 11 Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994, 77:307-316.
12. 12 Tomasson MH, Williams IR, Hasserjian R, Udomsakhdi C, McGrath SM, Schwaller J, et al.: TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood 1999, 93:1707-1714. This paper presents evidence that a fusion gene implicated in chronic eosinophilic leukemia is oncogenic in transgenic mice.
13. 13 Aprikian AG, Montgomery B, Bowen-Pope DF, Hickstein DD: Mechanism of Tel/PDGFRβ mediated myeloproliferation in transgenic mice [abstract]. Blood 1997, 90(Suppl 1):412. This paper presents evidence that a fusion gene implicated in chronic eosinophilic leukemia is oncogenic in transgenic mice.
14. 14 Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, et al.: Fusion of TEL, the ETS variant gene 6 (ETV6) to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia, Blood 1997, 90:2535-2540.
15. 15 Xiao S, Nalbolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, et al.: FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nature Genetics 1998, 18:84-87. This report establishes that in this stem cell myeloproliferative disorder, fusion of a putative oncogene, FGFR1, occurs with a unique partner gene. Abnormal signal transduction is likely to contribute to oncogenesis.
16. 16 Pebusque MJ, Popovici C, Guasch G, Adélaide J, Chaffanet M, Zhang B, et al.: Fibroblast growth factor receptor 1 is fused to different unrelated genes in stem cell myeloproliferative disorder linked to 8p11-12 chromosomal region [abstract]. Blood 1998, 92(Suppl 1):594. This report establishes that in this stem cell myeloproliferative disorder, fusion of a putative oncogene, FGFR1, occurs with a unique partner gene. Abnormal signal transduction is likely to contribute to oncogenesis.
17. 17 Popovici C, Zhang B, Grégoire M-J, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D, Pébusque M-J: The t(6;8) (q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to Fibroblast Growth Factor receptor 1. Blood 1999, 93:1381-1389. This report establishes that in this stem cell myeloproliferative disorder, fusion of a putative oncogene, FGFR1, occurs with a unique partner gene. Abnormal signal transduction is likely to contribute to oncogenesis.
18. 18 Bourgeade M-F, Défachelles AS, Cayre YE: Myc is essential for transformation by TL/platelet-derived growth factor receptor β (PDGFRβ). Blood 1999, 91:3333-3339.
19. 19 Yahata N, Ohyashiki K, Ohyashiki JH, Kimura Y, Miyazawa K, Kodama A, et al.: Late appearance of t(5;12) (q31;p12) in acute myeloid leukemia associated with eosinophilia. Cancer Genet Cytogenet 1998: 107,147-150.
20. 20 Wlodarska I, La Starza R, Baens M, Dierlamm J, Uyttebroeck A, Selleslag D, et al.: Fluorescent in situ hybridization characterisation of new translocations involving TEL (ETV6) in a wide range of hematologic malignancies. Blood 1998, 91:1399-1406.
21. 21 Martinez-Climent JA, Vizcarra E, Benet I, Marugan I, Terol MJ, Solano C, et al.: Cytogenetic response induced by interferon alpha in the myeloproliferative disorder with eosinophilia, T cell lymphoma and the chromosomal translocation t(8;13) (p11;q12). Leukemia 1998, 12:999-1000.
22. 22 Follows GA, Owen RG, Ashcroft AJ, Parapia LA: Eosinophilic myelodysplasia transforming to acute lymphoblastic leukaemia. J Clin Pathol 1999, 52:388-389.
23. 23 Vandergoten P, Janssen M, Madoe V, Vanstraelen D: A myeloproliferative disorder with eosinophilia, a translocation t(8;9) (p22;23) and a cerebellar degeneration in regression with interferon alpha therapy [abstract]. Acta Haematol 1998, 100(Suppl 1):8.
24. 24 Yamada O, Kitahara K, Imamura K, Ozasa H, Okada M, Mizoguchi H: Clinical and cytogenetic remission induced by interferon-α in a patient with chronic eosinophilic leukemia associated with a unique t(3;9;5) translocation. Am J Hematol 1998,58:137-141.
25. 25 Oliver JW, Deol I, Morgan DL, Tonk VS: Chronic eosinophilic leukemia and hypereosinophilic syndromes: proposal for classification, literature review, and report of a case with a unique chromosomal abnormality. Cancer Genet Cytogen 1998, 107:111-117.
26. 26 Weide R, Rieder H, Mehraein Y, Wolf M, Kaiser U, Seifart U, et al.: Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease. Br J Haematol 1997, 96:117-123.
27. 27 Malbrain ML, van den Berg H, Zachee P: Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete remission induced by interferon-alpha in a case with a unique chromosomal abnormality. Br J Haematol 1996, 92:176-183.
28. 28 Basara N, Markova J, Schmetzer B, Blau IW, Kiehl MG, Bischoff M, et al.: Chronic eosinophilic leukaemia: successful treatment with unrelated bone marrow transplantation. Leuk Lymphoma 1998, 32:189-194.
29. 29 Forrest DL, Horsman DE, Jensen CL, Berry BR, Dalal BI, Barnett MJ, Nantel SH: Myelodysplastic syndrome with hypereosinophilia and a nonrandom chromosomal abnormality dic(1;7): confirmation of eosinophil clonal involvement by fluorescent in situ hybridization. Cancer Genet Cytogenet 1998, 107:65-68.
30. 30 Kusanagi Y, Ochi H, Matsubara K, Ito M: Hypereosinophilic syndrome in a trisomy 21 fetus. Obstet Gynecol 1998, 92:701-702.
31. 31 Petithory JC: Familial eosinophilia: contribution of parasitology to its diagnosis. Bull Acad Natl Med 1998, 182:1823-1835.
32. 32 Navajas A, Cardenal I, Pinan MA, Ortiz A, Astigarraga I, Fdez-Teijeiro A: Hypereosinophilia due to myiasis. Acta Haematol 1998, 99:27-30.
33. 33 Mohri H, Motomura S, Okubo T: Unusual leucocytosis with eosinophilia by an allergic disease. Am J Hematol 1998: 57, 90-91.
34. 34 Ogata M, Ogata Y, Kohno K, Uno N, Ohno E, Ohtsuka E, et al.: Eosinophilia associated with adult T-cell leukemia: role of interleukin 5 and granulocyte-macrophage colony-stimulating factor. Am J Hematol 1998, 59:242-245.
35. 35 Oakley SP, Garsia RJ, Coates AS: Eosinophilic leukaemoid reaction and interleukin-5 in metastatic melanoma. Med J Aust 1998, 169:501.
36. 36 Watanabe M, Ono K, Ozeki Y, Yanaka S, Aida S, Okuno Y: Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol 1998, 28:559-562.
37. 37 Abe A, Tanimoto M, Towatari M, Matsuoka A, Kitaori K, Kato H, et al.: Acute myeloblastic leukemia (M2) with translocation (7;11) followed by marked eosinophilia and additional abnormalities of chromosome 5. Cancer Genet Cytogenet 1995, 83:37-41.
38. 38 Rioux JD, Stone VA, Daly MJ, Cargill M, Green T, Nguyen H, et al.: Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31 -33. Am J Hum Genet 1998, 63:1086-1094. In this linkage study of five generations of a kindred with eosinophilia, autosomal dominant inheritance with linkage to 5q31-33 was demonstrated.